share_log

4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

4:持股變動聲明-董事 YALE PHYLLIS R
美股SEC公告 ·  07/03 05:32
牛牛AI助理已提取核心訊息
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has been involved in a transaction with the company's stock on June 30, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and there is no information provided about the number of shares held after the action.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has been involved in a transaction with the company's stock on June 30, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and there is no information provided about the number of shares held after the action.
Bristol-Myers Squibb Co.(BMY)的報告人Phyllis R. Yale於2024年6月30日參與了該公司股票的交易。關於交易性質的具體細節,包括股票數量、交易價格和總價值,在公告中未予披露。Yale與發行人的關係未被特別說明,對行動後持有的股份數量也沒有提供任何信息。
Bristol-Myers Squibb Co.(BMY)的報告人Phyllis R. Yale於2024年6月30日參與了該公司股票的交易。關於交易性質的具體細節,包括股票數量、交易價格和總價值,在公告中未予披露。Yale與發行人的關係未被特別說明,對行動後持有的股份數量也沒有提供任何信息。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。